The Ebola virus, from the Filoviridae family, is the cause of Ebola hemorrhagic fever, which is often fatal for humans and many other mammals. The death rate is up to 90 percent.
Both the virus and the disease received their name from the Ebola River in the Democratic Republic of Congo, where the disease was observed for the first time in 1976.
The most common way of spreading the Ebola virus is through direct contact with an infected person, through their body fluids. Usually, it is not airborne, but it has been confirmed that it can be transmitted through very small drops that a person can inhale.
The Ebola virus is characterized by a weakening of the blood capillaries and the destruction of thrombocytes, which play a key role in the blood coagulation process. This leads to bleeding, which can lead to shock and eventually death.
The most common symptoms to appear in the first days are high temperature, headaches, joint and muscle aches, fatigue, and diarrhea. Amongst a smaller number of patients, sore throat, a rash, red eyes, vomiting blood, and blindness also appear as symptoms.
It is still not clear why and how some patients win the battle against the disease, but it is known that in the moments of dying, patients do not have a fully functioning immune system. Another important discovery is that the amount of vitamin C in the bodies of Ebola victims is equal to zero.
Somehow, the Ebola virus is consuming all the vitamin C supplies in the body, which results in the inability to coagulate blood, the complete destruction of the blood cells, bleeding, and death.
The mighty vitamin C can win the fight against the Ebola virus!
The Ebola virus causes bleeding much faster than any other fatal infection because the virus metabolizes quickly in the body and uses up all the vitamin C supplies. It is important to emphasize that hemorrhagic fever viruses are reaching epidemic proportions in countries where inhabitants have low levels of vitamin C in their bodies, as is the case in many African countries. Due to a high deficiency of vitamin C, the body is reaching the advanced stages of scurvyin only a matter of a few days, which leads to bleeding.
If an infected person does not receive treatment with high doses of vitamin C, the next thing that follows is shock and death, because the body does not have enough antibodies to destroy the virus. Many other antioxidants have similar effects, but the most effective is vitamin C because its simple chemical structure enables it to spread throughout the entire body with minimal difficulty.
Giving high doses of vitamin C intravenously to an infected person was first attempted by the American medical researcher and doctor Fred Klenner, who had experimented with high doses of this vitamin with many Ebola victims.
Working in highly advanced laboratory conditions, it was proved that vitamin C blocks the multiplication of the virus in the structural cells and stops the further weakening of the immune system.
Doctor Cathcart, who has worked and explored the intestinal tolerance of high doses of vitamin C, believes that victims of Ebola and other hemorrhagic fever viruses need a dose of 500,000 milligrams per day. An interesting fact about this is that treatment with high doses of vitamin C has practically no serious side effects other than nausea and diarrhea.
If this estimate is correct, it is clear that, at the beginning of the treatment, an infected person must receive high doses of vitamin C intravenously and should continue with this treatment until the disease is finally gone.
The death rate is very high, and death comes fast for victims of hemorrhagic fever caused by the Ebola virus, so doctors are of the opinion that,if a person gets infected, treatment should start right away.
Vitamin C therapy must start immediately, with high doses delivered intravenously, and it should not be stopped until the disease is completely gone and the patient is healthy.